GCP
DARE icon

GSA Capital Partners’s Dare Bioscience DARE Stock Holding History

GSA Capital Partners’s Portfolio DARE Stock Details DARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,696
Closed -$40K – 1586
2022
Q2 		$40K Sell
2,696
-7,800
-74% -$117K 0.01% 1302
2022
Q1 		$188K Sell
10,496
-1,324
-11% -$25K 0.03% 1186
2021
Q4 		$284K Buy
11,820
+10,816
+1,077% +$223K 0.04% 971
2021
Q3 		$20K Buy
+1,004
New +$19.8K ﹤0.01% 1362
2021
Q1 		– Sell
-12,027
Closed -$193K – 1180
2020
Q4 		$193K Buy
+12,027
New +$169K 0.03% 1002

Other funds holding DARE

FFS
Founders Financial Securities Towson, Maryland $1.77B AUM 17.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SAM
Soviero Asset Management New York $200M AUM 134.59% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GSA Capital Partners's DARE Position: Q3 2022 in Review

GSA Capital Partners sold out of Dare Bioscience (DARE) in Q3 2022, closing a stake of 2,696 shares — an estimated $40K sold.

GSA Capital Partners first reported a position in DARE in Q4 2020 and held it in 5 quarters. The position peaked at $284K in Q4 2021. 31 funds tracked by Wall St. Rank hold DARE as of Q3 2022.

  • GSA Capital Partners reported no remaining Dare Bioscience position as of Q3 2022 after selling out during the quarter.
  • GSA Capital Partners sold 2,696 Dare Bioscience shares in Q3 2022, an estimated $40K.
  • GSA Capital Partners first reported a position in Dare Bioscience in Q4 2020 and held it in 5 quarters.
  • GSA Capital Partners's Dare Bioscience position peaked at $284K in Q4 2021.
  • 31 funds tracked by Wall St. Rank held Dare Bioscience as of Q3 2022.

Based on GSA Capital Partners's 13F filing for Q3 2022, filed 14 Nov 2022.